Ziqi Cheng

452 total citations · 1 hit paper
15 papers, 323 citations indexed

About

Ziqi Cheng is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Ziqi Cheng has authored 15 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Ziqi Cheng's work include SARS-CoV-2 and COVID-19 Research (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Ferroptosis and cancer prognosis (3 papers). Ziqi Cheng is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Ferroptosis and cancer prognosis (3 papers). Ziqi Cheng collaborates with scholars based in China. Ziqi Cheng's co-authors include Chuanyong Guo, Jianye Wu, Jiao Feng, Jie Zhang, Liwei Wu, Jingjing Li, Yuanyuan Zheng, Baomin Feng, Xuan Lu and Jie Ji and has published in prestigious journals such as Free Radical Biology and Medicine, Life Sciences and Biomedicine & Pharmacotherapy.

In The Last Decade

Ziqi Cheng

15 papers receiving 322 citations

Hit Papers

Targeting fatty acid synthase modulates sensitivity of he... 2023 2026 2024 2025 2023 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis
    2023 107 citations Yan Li, Wenjuan Yang et al. Journal of Experimental & Clinical Cancer Research profile →

Peers

Ziqi Cheng
Ashley Eheim Germany
Yunpeng Wang China
Hongmei You China
Bhupender Kumar India
Lili Zhuo China
Yilin Wu China
Xiaoping Zou China
Xuanming Pan China
Ashley Eheim Germany
Ziqi Cheng
Citations per year, relative to Ziqi Cheng Ziqi Cheng (= 1×) peers Ashley Eheim

Countries citing papers authored by Ziqi Cheng

Since Specialization
Citations

This map shows the geographic impact of Ziqi Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziqi Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziqi Cheng more than expected).

Fields of papers citing papers by Ziqi Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziqi Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziqi Cheng. The network helps show where Ziqi Cheng may publish in the future.

Co-authorship network of co-authors of Ziqi Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Ziqi Cheng. A scholar is included among the top collaborators of Ziqi Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziqi Cheng. Ziqi Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Cheng, Ziqi, Xi Wu, Ling Pan, et al.. (2025). A single mutation at position 214 of influenza B hemagglutinin enhances cross-neutralization. Emerging Microbes & Infections. 14(1). 2467770–2467770. 1 indexed citations
2.
Huang, Xiande, et al.. (2024). Neutralization potency of the 2023-24 seasonal influenza vaccine against circulating influenza H3N2 strains. Human Vaccines & Immunotherapeutics. 20(1). 2380111–2380111. 3 indexed citations
3.
Zhang, Jie, Ziqi Cheng, Jie Ji, et al.. (2024). TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin‒proteasome system. Free Radical Biology and Medicine. 219. 31–48. 6 indexed citations
4.
Ji, Jie, Ziqi Cheng, Jie Zhang, et al.. (2024). Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4‐xCT pathway. Journal of Cellular and Molecular Medicine. 28(8). e18335–e18335. 10 indexed citations
5.
Li, Yan, Wenjuan Yang, Yuanyuan Zheng, et al.. (2023). Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis. Journal of Experimental & Clinical Cancer Research. 42(1). 6–6. 107 indexed citations breakdown →
6.
Huang, Xinping, Kai You, Yue Xiong, et al.. (2022). Hepatic DKK1-driven steatosis is CD36 dependent. Life Science Alliance. 6(1). e202201665–e202201665. 8 indexed citations
7.
Li, Penghui, Ying Liu, Ziqi Cheng, Xiaorui Yu, & Yinxiong Li. (2022). COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management. Biomedicine & Pharmacotherapy. 154. 113568–113568. 27 indexed citations
8.
Cheng, Ziqi, Dongsheng Guo, Kai You, et al.. (2022). Modeling MEN1 with Patient-Origin iPSCs Reveals GLP-1R Mediated Hypersecretion of Insulin. Cells. 11(15). 2387–2387. 2 indexed citations
9.
Yu, Qiang, Weiqi Dai, Jie Ji, et al.. (2022). Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c‐myc/hexokinase 2 pathway. Journal of Cellular and Molecular Medicine. 26(10). 3031–3045. 37 indexed citations
10.
11.
Ji, Jie, Jie Zhang, Liwei Wu, et al.. (2022). Cordycepin Protects against Hepatic Ischemia/Reperfusion Injury via Inhibiting MAPK/NF-κB Pathway. Mediators of Inflammation. 2022. 1–14. 17 indexed citations
12.
Xiong, Yue, Yan Chen, Xinping Huang, et al.. (2021). Icaritin ameliorates hepatic steatosis via promoting fatty acid β-oxidation and insulin sensitivity. Life Sciences. 268. 119000–119000. 15 indexed citations
13.
14.
Cheng, Ziqi, Xuan Lu, & Baomin Feng. (2020). A review of research progress of antitumor drugs based on tubulin targets. Translational Cancer Research. 9(6). 4020–4027. 37 indexed citations
15.
Cheng, Ziqi, et al.. (2015). Erythropoietin Pretreatment Exerts Anti-Inflammatory Effects in Hepatic Ischemia/Reperfusion-Injured Rats Via Suppression of the TLR2/NF-κB Pathway. Transplantation Proceedings. 47(2). 283–289. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashley Eheim Breakdown of academic impact, for papers by Yunpeng Wang Breakdown of academic impact, for papers by Hongmei You Breakdown of academic impact, for papers by Bhupender Kumar Breakdown of academic impact, for papers by Lili Zhuo Breakdown of academic impact, for papers by Yilin Wu Breakdown of academic impact, for papers by Xiaoping Zou Breakdown of academic impact, for papers by Xuanming Pan
Rankless by CCL
2026